Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults ages 18-65 years
Able to provide signed informed consent
Any gender
Diagnosis of PTSD as established by DSM-V
1 to 15 years since index trauma
Taking a stable dose of SSRI antidepressants for at least 3 months OR un-medicated for at least 2 months
Normal or corrected-to-normal vision
Normal or corrected-to-normal hearing
No intention of changing medication or psychotherapy for the duration of the study at the time of recruitment
You may not be if
Concurrent substance abuse
Use of any prescribed benzodiazepine
Lifetime bipolar disorder, psychotic disorder, autism, mental retardation. Comorbid mood and anxiety disorders will be permitted if they are not the primary focus of clinical attention
Active suicidality within past year, or history of suicide attempt in past 2 years
Any history of severe past drug dependence (i.e., a focus of clinical attention or a cause of substantial social or occupational difficulty)
Any unstable medical or neurological condition
Any history of brain surgery, of penetrating, neurovascular, infectious, or other major brain injury, of epilepsy, or of other major neurological abnormality (including a history of traumatic brain injury \[TBI\] with loss of consciousness for more than 24 hours or posttraumatic amnesia for more than 7 days)
Any psychotropic medication other than a stable dose of selective serotonin reuptake inhibitors (SSRIs)
Any change in accepted psychotropic medication within the past 2 months
Recent initiation (within the past 3 months) of cognitive-behavioral therapy or any evidence-based PTSD psychotherapy (Cognitive Processing Therapy \[CPT\], Prolonged Exposure \[PE\], Eye Movement -Desensitization and Reprocessing \[EMDR\]); continuation of established maintenance supportive therapy will be permitted
Significant hearing loss or severe sensory impairment
Enrollment in another research study testing an experimental, clinical, or behavioral intervention intended to affect symptoms initiated within the last 2 months, or intended enrollment within the next 2.5 months
